Key result
Higher waist circumference linked to ~59% greater ASCVD risk per 5 cm in CKM stage 0.
Why the study?
To investigate the association between obesity measures and the risk of incident ASCVD among adults at CKM stage 0 in a Middle Eastern population.
Do higher obesity measures increase the risk of incident ASCVD in adults at cardiovascular-kidney-metabolic syndrome stage 0?
Cohort (n=691)
No
Do higher obesity measures increase the risk of incident ASCVD in adults at cardiovascular-kidney-metabolic syndrome stage 0?
Even in individuals without traditional cardiovascular-kidney-metabolic risk factors (CKM stage 0), higher abdominal obesity measures (waist circumference, waist-to-height ratio, waist-to-hip ratio) are associated with a significantly increased long-term risk of ASCVD, whereas BMI is not.
Answers are grounded in this paper and cite their sources.
Abdominal obesity may refine ASCVD risk assessment in CKM stage 0; leaves open causal role and preventive interventions.
To investigate the association between obesity measures and the risk of incident atherosclerotic cardiovascular disease (ASCVD) among adults at cardiovascular-kidney-metabolic syndrome (CKM) stage 0 in a Middle Eastern population. Data were obtained from 691 adults (47.6% women; mean [SD] age, 40.4 [10.4] years) in the Tehran Lipid and Glucose Study who were free of CKM risk factors and were followed for a median of 19.6 years. Associations of body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR), and waist-to-hip ratio (WHR) with incident ASCVD were assessed using Cox proportional hazards models and restricted cubic spline analyses. During follow-up, 58 participants (8.4%) developed ASCVD. Linear dose–response relationships were observed between WC, WHtR, and WHR and incident ASCVD risk (all P for non-linearity >0.3). After adjustment for education level and the PREVENT 10-year total CVD risk score, the HRs (95% CIs) per 1 kg/m 2 higher BMI, 5 cm higher WC, 0.05 higher WHtR, and 0.05 higher WHR were 1.15 (0.98–1.35; P = 0.083), 1.59 (1.28–1.98; P <0.001), 2.23 (1.47–3.40; P <0.001), and 1.67 (1.34–2.08; P <0.001), respectively. Sensitivity analyses using Iranian WC cutoffs, as well as models adjusted for individual covariates in place of the CVD risk score, together with analyses using multiple imputation and inverse probability weighting, yielded generally consistent results. Even in the absence of CKM risk factors, higher abdominal obesity measures were associated with a higher long-term risk of ASCVD.
No takes yet. Share an insight, caveat, or question.
Masrouri et al. (2026) conducted a cohort in Cardiovascular-kidney-metabolic syndrome (CKM) stage 0 (n=691). Higher waist circumference (per 5 cm increment) vs. Lower waist circumference was evaluated on Incident atherosclerotic cardiovascular disease (ASCVD) (HR 1.59, 95% CI 1.28-1.98, p=<0.001). In adults at cardiovascular-kidney-metabolic syndrome stage 0, each 5 cm higher waist circumference was associated with a 59% higher risk of incident atherosclerotic cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: